I-Pouchitis ingaba yinkinga engapheliyo kubantu abane-J-Pouch
Yintoni iPouchitis?
I-Pouchitis yimeko echaphazela abantu abane- j-poch (i-pouch ye-leal-anal anastomosis [IPAA]) otyando lwe-ulcerative colitis. Indlela yokwenza i-pouchitis ayiqondwa kakuhle, kwaye kucatshangelwa ukuba ingaquka iintlobo ezahlukeneyo zezifo. Yiyona nkxalabo eqhelekileyo kubantu abane-j-pocks.
Izibonakaliso ze pouchitis zingaquka:
- ngokunyuka rhoqo kunye nokunyanzeliswa kwezibilini
- ukuxinwa kwesisu
- ukuphuma kwegazi
- umkhuhlane
I-Pouchitis isabela ngokunyanga kwonyango ngamayeza aphikisayo kodwa inokuphindaphinda malunga neyesibini kwisigulane sezigulane. Phantse i-10% yezigulane zifumana i-pouchitis ephindayo engaphenduliyo unyango lwe-antibiotic. Ezi zihlandlo eziphindaphindiweyo ze-pouchitis zingabangela ukwehla komgangatho wobomi kubantu abane-j-poch.
Ukufumana unyango kwi-pouchitis, ngokukodwa kwithuba emva kokuhlinzwa, kubaluleke kakhulu. Nabani na oye wayenokutyunjwa kwebhokisi le-pelvic kufuneka axhalele ugqirha wakhe ngokukhawuleza xa isikhombisi sibonakala "siphume" kwaye kukho iimpawu zentlungu, umkhuhlane kunye negazi kwisigxina.
Kutheni iiProbiotics ziyakunceda?
Abaphandi bafumanisa ukuba abantu abafumana i-pouchitis baneebhaktheriya ezincitshisiweyo ezincinci, ezibizwa ngokuthi i-lactobacilli kunye ne-bifidobacteria, kwindlela yabo yokugaya. Isinyathelo esilandelayo esilungileyo kukuqhuba izilingo ukuba zibone ukuba ukwandisa ibhaktheriya encedo kwi-digestive tract kunokunceda ukuphucula iimpawu ze-pouchitis.
Izibonelelo zale bhaktheriya ezinokuthiwa zibizwa ngokuthi "iiprobiotics" kwaye zingabandakanya iintlobo ezahlukeneyo zeentsholongwane zebhakteria.
Ubu bungqina bokusetyenziswa kweProbiotics
Izilingo ezimbini eziziimfama ezingaboniyo, ezinokulawulwa kwe-placebo zenziwa ukuba zibone ukuba idibanti yebhaktheriya-lyophilized-ezine ezine- Lactobacillus , iintlobo ezintathu ze- Bifidobacterium kunye nohlobo olulodwa lwe- Streptococcus - (olubizwa ngokuba yi-VSL # 3) luya kunceda ekuphuleni iimpawu ze-pouchitis.
Olunye uvavanyo lwafumanisa ukuba emva kweenyanga ezili-9, i-85% yezigulane ezithatha i-VSL # 3 azizange ziphinde ziphinde ziphinde zibuyele kwi-pouchitis. Zonke izigulane ezingama-20 ezifumene i-placebo zibuyiselwa kwakhona. Kwilingo lesibini, i-85% yezigulane ezithatha i-VSL # 3 azizange ziphinde zibuyele emva konyaka omnye wonyango. Yonke enye yezigulane ezitholayo i-placebo zabuyela kwakhona. Iziphumo zezifundo zimbini zinika inkxaso efanelekileyo yokuba iiprobioti eziqulethe iintlobo ezithile zebhaktheriya zinokuba luncedo kwabo bantu abane-j-pocks abaye bafumana i-pouchitis ephindaphindiweyo.
Kwesinye isifundo, izigulane ezingama-16 ze-23 ezine-pouchitis ezinomsebenzi, zincinci zenze i-remission emva kweeveki ezine ze-VLS # 3. Nangona abalobi belo cwaningo baphetha ngokuthi ama-probiotics asebenzayo kwi-pouchitis emnene, afuna ukuphanda ngakumbi.
Izilingo ezingaphezulu ziye zavavanya ezinye iifomoustic formulations, eziquka uLactobacillus rhamnosus GG kunye neLacbabacillus acidophilus kunye neBifidobacterium lactis . Ezi zifundo azibonanga ukuba ezi probiotics zinefuthe elihle kwi-pouchitis esebenzayo; Nangona kunjalo, olunye uvavanyo lwabonisa ukuba i- rhamnosus GG yayinceda ekulibazisekeni kokuqala kwe-pouchitis xa unyango lwaqala ngokukhawuleza emva kokutyunjwa kwe-j-pouch .
Ngaphantsi
Ngelixa ubungqina bonyango buncinane kwi sihloko seprobiotics, kulungile ukuthetha ukuba ngelixa i-probiotiki inokukunceda ukugcina ukuxolelwa, ayiluncedo ekuphatheni i-pouchitis.
Ugqirha wakho uya kukwazi ukukunceda ukuba i-probiotics iyanceda i-pouchitis, kunye nemveliso eyayisebenzisayo kunye nokuba ungathatha buninzi.
Iingongoma ezibalulekileyo zokukhumbula:
- I-Probiotics inokukunceda ukugcina ukuxolelwa emva kwe-pouchitis uphathwe ngamayeza okubulala okanye ukulibala ukuqala kokuqala kwe-pouchitis
- Iiprobiotiki azikabonakali zincedo ekuphatheni i-pouchitis enzima, enamandla
- Kubalulekile ukuxubusha ukusetyenziswa kweerbiotics kunye nodokotela ukuqinisekisa ukuba uhlobo olufanelekileyo kunye neemali zithathwa
- Ubungqina bokusetyenziswa kweprobiotics abukapheli, kwaye iziphumo zezifundo ezizayo ziyakutshintsha ukusetyenziswa kweziprobiotics ze-pouchitis
> Imithombo:
> UElahi B, uNicfar S, uDerakhshani S, UVafaie M, Abdollahi M. "Ngenzuzo yeprobiotics ekulawuleni i-pouchitis kwizigulane ezithatha isikhwama se-ileal anal anastomosis: uhlalutyo lweemeta lwezilingo zokulawulwa kweeklinikhi. " Dig Dig Dis Sci. Meyi 2008. 53: 1278-1284.
> Gionchetti P, Rizzello F, Morselli C, Poggioli G, Tambasco R, Calabrese C, uBrigidi P, Vitali B, Straforini G, Campieri M. "Iiprobi ze-high dose probiotics zonyango lwe pouchitis. "I- Dis Colon Rectum Dec 2007 50: 2075-2082.
> Gionchetti P, Rizzello F, Venturi A, et al. "I-bacteriotherapy yomlomo njengonyango lolondolozo kwizigulane ezine-pouchitis engapheliyo: ityala elilawulwa ngokuphindaphindiweyo, elinesigqeba." I- Gastroenterology. 2000 119: 305-309.
> MP Gosselink, uSchouten WR, van Lieshout LM, Hop WC, uLanan JD, uRuverer-van Embden JG. "Ukukhawuleza kokuqala kokusebenzisa i-pouchitis ngokudla ngomlomo we-probiotic strain Lactobacillus rhamnosus GG. "I- Dis Colon Rectum. NgoJuni 2004 47: 876-884.
> Kuisma J, Mentula S, Jarvinen H, et al. "Impembelelo yeLactobacillus rhamnosus GG kwisikhumba se-ileal ukuvuvukala kunye nemifuno emininzi ." Ukutya kwe-Pharmacol Ther. 2003 17: 509-515.
> Yenza i-KO, i-Line PD, i-Aabakken L, et al. "Uvavanyo lwe-mucosal ukuvuvukala kunye nokusabalalisa ekuphenduleni iiprobitics kwizigulane eziqhutywe ngesikhwama se-ileal anal anastomosis ye-ulcerative colitis." U- Scand J Gastroenterol. 2003 38: 409-414.
> Liu Z1, Ingoma H, Shen B. "I-Pouchitis: ukhuselo kunye nonyango." I-Curr Opin I-Metab Care ye-Metab Care . 2014 Sep; 17: 489-495.
> Mimura T, Rizzello F, uHelwig U, et al. "Kanye kwiprogram yokwelapha i-probiotic (i-VSL # 3) ephakamileyo imihla ngemihla yokugcina ukuxolelwa kwi-pouchitis ephindaphindiweyo okanye yokukhanyela." 2004 53: 108-114.
> Ruseler-van Embden JG, uSchouten WR, van Lieshout LM. "I-Pouchitis: kubangelwa ukungalingani kwamanqwana?" Gut. 1994 35: 658-664.